NCT04754373 - A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 13, 2018

Primary Completion Date

December 6, 2021

Study Completion Date

December 6, 2021

Conditions

Elevated Triglycerides

Interventions

DIETARY_SUPPLEMENT

GFA-918

Participants will be instructed to take one GFA-918 (125000 FIP Units of Lipase AY) capsule twice per day with their morning and evening meals for 12 weeks.

OTHER

Placebo

Participants will be instructed to take one Placebo capsule twice per day with their morning and evening meals for 12 weeks.

Trial Locations (2)

N6A 5R8

KGK Science, London

M2K 1E2

Canadian College of Naturopathic Medicine, Toronto